Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis
NCT00004316Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jun 1995
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of capsaicin in interstitial cystitis (IC) and vulvar vestibulitis syndrome (VVS) (5 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Optimal safe dose of intravesical capsaicin. Started Jun 1995; status: completed.
02
Drugs
capsaicin
03
Conditions
interstitial cystitis (IC)vulvar vestibulitis syndrome (VVS)
Beyond the preview
Go deeper on NCT00004316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004316.